Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kyowa Kirin buys back Tivozanib rights from AVEO oncology

biospectrumasiaAugust 04, 2019

Tag: Kyowa Kirin , Tivozanib , Aveo Oncology

PharmaSources Customer Service